Literature DB >> 10457739

The adaptations of a quality of life questionnaire for routine use in clinical practice: the Chronic Respiratory Disease Questionnaire in cystic fibrosis.

J Bradley1, M Dempster, E Wallace, S Elborn.   

Abstract

The assessment of quality of life (QoL) is necessary to monitor the course of disease and to assess the effect of new and existing interventions in clinical practice. This will only be achieved if QoL can be measured accurately and routinely. The aim of this study was to demonstrate the methodology involved in the adaptation and shortening of the Chronic Respiratory Disease Questionnaire (CRDQ) in a population of adults with cystic fibrosis (CF). A single interviewer administered the CRDQ to a sample of 45 adult patients (32 males) with CF prior to assessment of spirometric measures of lung function. Those patients whose lung function was stable at the time of study and who could attend for a retest within 14 days were asked to complete the questionnaire at a subsequent visit (n = 10). The mean interval between visits was 7 days (range 5-14 days). Correlations between spirometry and CRDQ dimensions ranged from -0.003 to 0.426. The fatigue, emotion and mastery dimensions showed high internal consistency and adequate construct validity. In the small number of patients suitable for retest, the results indicated that the dimensions exhibited adequate test-retest reliability. In contrast, low internal consistency was demonstrated for the dyspnoea dimension. The fatigue, emotion and mastery dimensions could be reduced, in terms of their number of items, without a substantial loss in explanatory power. This study suggests that QoL measurement can be made convenient and, thus, more easily accessible for routine clinical assessment.

Entities:  

Mesh:

Year:  1999        PMID: 10457739     DOI: 10.1023/a:1026437214170

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  13 in total

1.  Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation.

Authors:  M H Yacoub; N R Banner; A Khaghani; M Fitzgerald; B Madden; V Tsang; R Radley-Smith; M Hodson
Journal:  J Heart Transplant       Date:  1990 Sep-Oct

2.  Quality of life for children with disabilities.

Authors:  B Lindström; B Eriksson
Journal:  Soz Praventivmed       Date:  1993

3.  Measurement of quality of well being in a child and adolescent cystic fibrosis population.

Authors:  D I Czyzewski; M J Mariotto; L K Bartholomew; S H LeCompte; M M Sockrider
Journal:  Med Care       Date:  1994-09       Impact factor: 2.983

4.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

5.  Quality of life in patients with cystic fibrosis.

Authors:  W de Jong; A A Kaptein; C P van der Schans; G P Mannes; W M van Aalderen; R G Grevink; G H Koëter
Journal:  Pediatr Pulmonol       Date:  1997-02

6.  Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects.

Authors:  J M Wolter; S D Bowler; P J Nolan; J G McCormack
Journal:  Eur Respir J       Date:  1997-04       Impact factor: 16.671

7.  Comparison of the sensitivity to change of long and short form pain measures.

Authors:  C Jenkinson; D Carroll; M Egerton; T Frankland; H McQuay; C Nagle
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

8.  Cystic fibrosis: current survival and population estimates to the year 2000.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Thorax       Date:  1991-12       Impact factor: 9.139

9.  Heart-lung transplantation in cystic fibrosis: predictions for the next decade in England and Wales.

Authors:  J S Elborn; D J Shale; J R Britton
Journal:  Respir Med       Date:  1994-02       Impact factor: 3.415

10.  Quality of life measurements in eating disorders, angina, and transplant candidates: are they comparable?

Authors:  M Keilen; T Treasure; U Schmidt; J Treasure
Journal:  J R Soc Med       Date:  1994-08       Impact factor: 18.000

View more
  4 in total

1.  Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial.

Authors:  J Wolter; S Seeney; S Bell; S Bowler; P Masel; J McCormack
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

Review 2.  Quality of life in children and adolescents with cystic fibrosis: implications for optimizing treatments and clinical trial design.

Authors:  Janice Abbott; Louise Gee
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 3.  Patient-reported outcomes in cystic fibrosis.

Authors:  Christopher H Goss; Alexandra L Quittner
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

Review 4.  Measuring and reporting quality of life outcomes in clinical trials in cystic fibrosis: a critical review.

Authors:  Janice Abbott; Anna Hart
Journal:  Health Qual Life Outcomes       Date:  2005-03-24       Impact factor: 3.186

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.